News
-
-
PRESS RELEASE
Abivax Announces Acceptance of Additional Late-Breaking Abstract from the ABTECT Phase 3 Induction Trials to be Presented at 2025 United European Gastroenterology (UEG) Meeting
Abivax announces acceptance of additional late-breaking abstract from the ABTECT Phase 3 induction trials to be presented at 2025 United European Gastroenterology (UEG) Meeting -
-
PRESS RELEASE
Abivax Announces Presentation of Late-Breaking Abstract for Obefazimod from the ABTECT Phase 3 Induction Trials at 2025 United European Gastroenterology (UEG) Meeting
Abivax announces presentation of late-breaking abstract for Obefazimod at 2025 United European Gastroenterology Meeting, showcasing potential as a new therapy for ulcerative colitis -
-
-
-
-
-